Indefinite Delivery Contract SPE2DX25D1000

Award Date 3/7/25
Last Date to Order 3/6/35
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award was issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The single-award Indefinite Delivery Contract (IDC), valued at $4,999,999.00, aims to establish a Pharmaceutical Prime Vendor Global Program Generation V to provide worldwide pharmaceutical support, including brand-name, generic, and specialty drugs, vaccines, syringes, and other...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, covers a wide range of pharmaceutical and medical supply products to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes,...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 contract, running through December 2036, is for the DLA's Pharmaceutical Prime Vendor Global Program Generation V, which provides worldwide pharmaceutical and medical supply support to the Department of Defense, U.S. Coast...
The federal contract IDV award is a $999,999,999 Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,999,999, is a single-award IDC with a period of performance from November 2025 through December 2036. The purpose of the contract is to establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global...
The federal contract IDV award is an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, has an ultimate completion date of December 31, 2036 and was awarded on November 13, 2025. The purpose of this IDC is to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to...
The federal contract IDV awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp is an Indefinite Delivery Contract (IDC) valued at $999,999,999 through December 2036. The contract provides worldwide pharmaceutical support, including brand-name, generic, and specialty medications, vaccines, medical supplies, and equipment, to the Defense Health Agency, U.S. Department of Defense, U.S. Coast Guard, and other federal agencies and healthcare...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, is a single-award IDC with a period of performance running through December 31, 2036. The purpose of this contract is to establish Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contracts to provide worldwide...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The $999,999,999 IDC has a base period of 30 months and three 30-month option periods, running through November 2036. The contract is intended to establish Prime Vendor...
The federal contract IDV award is an Indefinite Delivery Contract (IDC) valued at $4,999,999 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, which runs through December 31, 2036, provides for the procurement of a comprehensive range of pharmaceutical and medical supply products, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. This IDC serves as a primary...

The federal contract IDV award, valued at $26,366,625,013.21, was issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This single-award Indefinite Delivery Contract (IDC) has an ultimate completion date of March 6, 2035 and supports the TRICARE North program.

The purpose of this IDC is to establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), which provides worldwide pharmaceutical (brand, generic, specialty) and related product support to the Defense Health Agency, Department of Defense customers, the United States Coast Guard, and other government agencies. The contract will cover medical pharmaceuticals in the 6505 stock catalog/schedule and the current National Drug Code (NDC) database, with separate distribution fees for brand/generic and specialty drugs. This is an unrestricted, fully competitive acquisition awarded on a Lowest Price Technically Acceptable (LPTA) basis, with the intention to make multiple regional awards to at least three different contractors.

Generated 6/6/25, 9:54 AM